asthma - home - association pulmonaire du québec medications (inhaled corticosteroids and...

VENTOLIN ® MDI 100 µg salbutamol FLOVENT ® MDI 50 µg • 125 µg 250 µg fluticasone propionate FORADIL ® AEROLIZER ® 12 µg formoterol fumarate/ capsules ADVAIR ® MDI 125/25 µg 250/25 µg fluticasone propionate and salmeterol VENTOLIN ® DISKUS ® 200 µg salbutamol FLOVENT ® DISKUS ® 50 µg • 100 µg 250 µg • 500 µg fluticasone propionate SEREVENT ® DISKUS ® 50 µg salmeterol xinafoate ADVAIR ® DISKUS ® 100/50 µg • 250/50 µg 500/50 µg fluticasone propionate and salmeterol AIROMIR ® MDI 100 µg salbutamol PULMICORT ® TURBUHALER ® 100 µg • 200 µg 400 µg budesonide OXEZE ® TURBUHALER ® 6 µg • 12 µg formoterol fumarate ZENHALE ® MDI 100/5 μg • 200/5 μg mometasone furoate and formoterol fumarate SYMBICORT ® TURBUHALER ® 100/6 µg • 200/6 µg budesonide and formoterol fumarate BRICANYL ® TURBUHALER ® 0.5 mg terbutaline sulfate QVAR ® MDI 50 µg • 100 µg beclomethasone dipropionate ACCOLATE ® 20 mg zafirlukast / tablets ALVESCO ® MDI 100 µg • 200 µg ciclesonide SINGULAIR ® 10 mg montelukast / tablets 4 mg montelukast / granules per packet 4 mg • 5 mg montelukast / chewable tablets XOLAIR ® 150 mg vial omalizumab/ sterile powder for reconstitution subcutaneous injections ASMANEX ® TWISTHALER ® 100 µg • 200 µg 400 µg mometasone furoate Short-acting bronchodilators Inhaled corticosteroids Long-acting bronchodilators Combination medications (inhaled corticosteroids and long-acting bronchodilators) Leukotriene receptor antagonists Long-acting muscarinic antagonist IgE-neutralizing antibody (Anti-IgE) It is a chronic respiratory disease characterized by inflammation and partial reversible obstruction of the bronchi, and affecting a large number of children and adults. Because of its hypersensitivity, the respiratory tract reacts by contracting and congesting when irritated, which makes breathing difficult. Obstruction is caused by three mechanisms: • inflammation of the inner bronchial wall; • contraction of the muscle fibers surrounding the bronchi (bronchoconstriction); • overproduction of mucus (thick secretions) clogging the bronchial tubes. WHAT IS ASTHMA? INHALATION CHAMBER HOW ASTHMA WORKS Did you know that inhalers used without an inhalation chamber propel only 10% of the medication into the lungs and that almost 80% of the medication is simply deposited in the mouth? All inhalers should be used with an inhalation chamber. As a result, you will: • Optimize the administration of the drug (better deposition, better synchronization and simpler technique); • Reduce the side effects of certain drugs. This bronchial obstruction can lead to the following symptoms: • shortness of breath; • chest tightness; • wheezing; • cough; • mucus production. Asthma cannot be cured but it can be managed. The best way to do so is to properly understand the illness, as well as its signs and symptoms, to recognize and avoid the triggers of attacks, and to adequately take the prescribed medication. Wall inflamed and thickened Thightened muscles Relaxed muscles Normal airway Asthmatic airway Asthmatic airway during attack SPIRIVA ® RESPIMAT ® 2.5 μg Tiotropium bromide BREO ® ELLIPTA ® 100/25 μg • 200/25 μg fluticasone furoate and vilanterol ASTHMA MEDICATIONS CHART Selected list of relievers Selected list of controllers Head office : 6070 Sherbrooke Street East, office 104 Montreal (Quebec) H1N 1C1 www.pq.lung.ca

Upload: dangkhanh

Post on 26-Mar-2018

220 views

Category:

Documents

2 download

Report

Download

Embed Size (px):

TRANSCRIPT

Page 1: ASTHMA - Home - Association pulmonaire du Québec medications (inhaled corticosteroids and long-acting bronchodilators) Long-acting muscarinic Leukotriene receptor antagonists antagonist

VENTOLIN® MDI

100 µgsalbutamol

FLOVENT® MDI

50 µg • 125 µg250 µgfluticasone propionate

FORADIL®

AEROLIZER®

12 µgformoterol fumarate/capsules

ADVAIR® MDI

125/25 µg 250/25 µgfluticasone propionate and salmeterol

VENTOLIN® DISKUS®

200 µgsalbutamol

FLOVENT® DISKUS®

50 µg • 100 µg 250 µg • 500 µgfluticasone propionate

SEREVENT® DISKUS®

50 µgsalmeterol xinafoate

ADVAIR® DISKUS®

100/50 µg • 250/50 µg 500/50 µgfluticasone propionate and salmeterol

AIROMIR® MDI

100 µgsalbutamol

PULMICORT® TURBUHALER®

100 µg • 200 µg 400 µgbudesonide

OXEZE® TURBUHALER®

6 µg • 12 µgformoterol fumarate

ZENHALE®

MDI

100/5 μg • 200/5 μg mometasone furoate and formoterol fumarate

SYMBICORT® TURBUHALER®

100/6 µg • 200/6 µgbudesonide and formoterol fumarate

BRICANYL® TURBUHALER®

0.5 mgterbutaline sulfate

QVAR®

MDI

50 µg • 100 µgbeclomethasone dipropionate

ACCOLATE®

20 mgzafirlukast / tablets

ALVESCO®

MDI

100 µg • 200 µgciclesonide

SINGULAIR®

10 mgmontelukast / tablets4 mgmontelukast / granules per packet4 mg • 5 mgmontelukast / chewable tablets

XOLAIR®

150 mg vialomalizumab/ sterile powder for reconstitution subcutaneous injections

ASMANEX® TWISTHALER®

100 µg • 200 µg 400 µgmometasone furoate

Short-acting bronchodilators

Inhaled corticosteroids

Long-acting bronchodilators

Combination medications (inhaled corticosteroids and long-acting bronchodilators)

Leukotriene receptor antagonistsLong-acting muscarinic antagonist

IgE-neutralizing antibody (Anti-IgE)

It is a chronic respiratory disease characterized by inflammation and partial reversible obstruction of the bronchi, and affecting a large number of children and adults. Because of its hypersensitivity, the respiratory tract reacts by contracting and congesting when irritated, which makes breathing difficult.

Obstruction is caused by three mechanisms:

• inflammation of the inner bronchial wall;• contraction of the muscle fibers surrounding the bronchi (bronchoconstriction);• overproduction of mucus (thick secretions) clogging the bronchial tubes.

WHAT IS ASTHMA?

INHALATION CHAMBER

HOW ASTHMA WORKS

Did you know that inhalers used without an inhalation chamber propel only 10% of the medication into the lungs and that almost 80% of the medication is simply deposited in the mouth? All inhalers should be used with an inhalation chamber.

As a result, you will:

• Optimize the administration of the drug (better deposition, better synchronization and simpler technique);

• Reduce the side effects of certain drugs.

This bronchial obstruction can lead to the following symptoms:

• shortness of breath;• chest tightness;• wheezing;• cough;• mucus production.

Asthma cannot be cured but it can be managed. The best way to do so is to properly understand the illness, as well as its signs and symptoms, to recognize and avoid the triggers of attacks, and to adequately take the prescribed medication.

Wall inflamed and thickened

Thightened musclesRelaxed muscles

Normal airway Asthmatic airway Asthmatic airway during attack

SPIRIVA®

RESPIMAT®

2.5 μgTiotropium bromide

BREO® ELLIPTA®

100/25 μg • 200/25 μg fluticasone furoate and vilanterol

ASTHMAMEDICATIONS CHART

Selected list of relievers

Selected list of controllers

Head office : 6070 Sherbrooke Street East, office 104Montreal (Quebec) H1N 1C1www.pq.lung.ca